BDNF/TrkB signaling shows a critical role in mitigating AD symptoms [45], in slowing Aβ-induced neurodegeneration, sustaining neuron viability, and alleviating synaptic alterations, which can avoid cognitive damage [46,47]. The gene discussed is NTRK2; the disease is Alzheimer disease.